|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 320 WESTLAKE AVE N STE 100 |
Address2 | |
| City | SEATTLE |
State | WA |
Zip Code | 98109-5233 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 17022-12
|
||||||||
|
6. House ID# 330350000
|
||||||||
| TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Phlip Cash, Public Policy Specialist |
Date | 08/28/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S 1693, Wired for Health Care Quality Act, all provisions relating to health information technology, health information, health care quality measurement, and payments to health care organizations; HR 1368, Personalized Health Information Act of 2007, all provisions relating to health information technology, health information, health care quality measurement, and payments to health care organizations; HR 4460, Health Care Choice Act of 2007, all provisions relating to the individual health insurance market;
S 2477, Health Care Choice Act of 2007, all provisions relating to the individual health insurance market; HR 4848, To extend for one year parity in the application of certain limits to mental health benefits, and for other purposes; all provisions regarding mental health benefits; HR 3997, Heroes Earnings Assistance and Relief Tax Act of 2007; all provisions regarding mental health benefits; S. 558, Mental Health Parity Act of 2007, all provisions regarding mental health benefits; HR 1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007, all provisions regarding mental health benefits; HR 1663, Medicare Mental Health Modernization Act of 2007, all provisions regarding mental health benefits; HR 2795, Small Business Health Act Options Program Act of 2008, all provisions relating to the small business health insurance market; S 2064, Nurse Training and Retention Act, all provisions relating to training and retention of health care workers and workforce shortage issues; small business health insurance market reform; mental health parity; nursing and physician workforce issues; health information technology; health system reform ongoing conversations about health system reform proposals; individual health insurance market reform
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Diana |
Birkett |
|
|
|
Howard |
Cohen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
HR 2764, The Consolidated Appropriations Act of 2008, all provisions relating to comparative effectiveness research; HR 2184, Enhanced Health Care Value for All Act of 2008, all provisions relating to comparative effectiveness research; HR 493, Genetic Information Nondiscrimination Act of 2007, all provisions relating to genetic information and privacy protections for such information;
S 358, Genetic Information Nondiscrimination Act of 2007, all provisions relating to genetic information and privacy protections for such information; genetic non-discrimination; Comparative effectiveness research ;
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Diana |
Birkett |
|
|
|
Howard |
Cohen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 3162, Children's Health and Medicare Protection Act of 2007, all provisions relating to comparative effectiveness research, Medicare (including Medicare Advantage), Medicaid, and SCHIP; HR 2639, Promoting Health for Future Generations Act of 2007, all provisions relating to Medicare Advantage Medical Savings Accounts; S 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007, all provisions relating to Medicare (including Medicare Advantage and Medicare Secondary Payor), Medicaid, and SCHIP;
HR 5613, Protecting the Medicaid Safety Net Act of 2008, all provisions relating to CMS regulatory action on Medicaid;
S 2620, To provide for a temporary increase of the Federal medical assistance percentage under the Medicaid Program, and for other purposes; all provisions relating to Medicaid payment; HR 5268, To provide for a temporary increase of the Federal medical assistance percentage under the Medicaid Program, and for other purposes; all provisions relating to Medicaid payment;
S 1701, To provide for the extension of transitional medical assistance (TMA) and the abstinence education program through the end of fiscal year 2007, and for other purposes; provisions relating to Medicare Advantage; HR 5480, Medicare Funding Warning Response Act of 2008, all provisions relating to Medicare (including Medicare Advantage), health information technology, and health care quality measurement; S 2662, Medicare Funding Warning Response Act of 2008, all provisions relating to Medicare (including Medicare Advantage), health information technology, and health care quality measurement; HR 976, Children's Health Insurance Program Reauthorization Act of 2007, all provisions relating to children's health and dental insurance coverage; HR 3963, Children's Health Insurance Program Reauthorization Act of 2007, all provisions relating to children's health and dental insurance coverage; HR 2206, U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007, all provisions relating to SCHIP funding; S 334/ HR 3163, Healthy Americans Act, all provisions relating to health insurance coverage, Medicare, Medicaid, SCHIP, and employer taxes related to health insurance;
Medicare Advantage Payment; Medicaid payment and state plans oversight; SCHIP reauthorization; S.3101 - Medicare Improvement for Patients and Providers Act of 2008; HR 6331 - Medicare Improvement for Patients and Providers Act of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Executive Office of the President (EOP), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Diana |
Birkett |
|
|
|
Howard |
Cohen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
tax exempt oversight - ongoing tracking and communications on the new IRS for 990
17. House(s) of Congress and Federal agencies Check if None
Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Diana |
Birkett |
|
|
|
Howard |
Cohen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
5 |
|
||||||
| 2 |
|
6 |
|
||||||
| 3 |
|
7 |
|
||||||
| 4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 3 | 5 |
| 2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 5 | 9 |
| 2 | 6 | 10 |
| 3 | 7 | 11 |
| 4 | 8 | 12 |